BioMarin Pharmaceutical Inc.

06/24/2022 | Press release | Distributed by Public on 06/24/2022 05:22

BioMarin Receives Positive CHMP Opinion in Europe for Valoctocogene Roxaparvovec Gene Therapy to Treat Adults with Severe Hemophilia A